Drug Profile
Iodine-based oral rinse - Biomedical Development Corporation
Alternative Names: Frio mouth rinse; Frio oral rinse; iCLEAN/FRIO; Iocide; Iocide oral rinseLatest Information Update: 12 Jan 2022
Price :
$50
*
At a glance
- Originator Biomedical Development Corporation
- Developer Biomedical Development Corporation; Foundation Of Collaborative Unique Science; Methodist Healthcare Ministries of South Texas; National Institute of Nursing Research
- Class Disinfectants; Halogens
- Mechanism of Action Endotoxin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Gingivitis
- No development reported Candidiasis; Periodontitis; Urinary tract infections
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for phase-I development in Candidiasis in USA (PO, Gargle)
- 28 Apr 2018 No recent reports of development identified for phase-I development in Periodontitis in USA (PO, Gargle)
- 28 Apr 2018 No recent reports of development identified for phase-I development in Urinary-tract-infections in USA (PO, Gargle)